SHC PHARMACY LIMITED

SHC PHARMACY LIMITED

Company Registration Number:
SC130669 (Scotland)

Unaudited statutory accounts for the year ended 31 March 2022

Period of accounts

Start date: 1 April 2021

End date: 31 March 2022

SHC PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2022

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

SHC PHARMACY LIMITED

Directors' report period ended 31 March 2022

The directors present their report with the financial statements of the company for the period ended 31 March 2022

Additional information

The company was acquired by The M&D Green Group Limited on 31 January 2022. The trade and assets of the company were hived across to M&D Dispensing Chemist Limited, a fully owned subsidiary of The M&D Green Group Limited on 31 March 2022. From 1 April 2022, the Company ceased to trade and will shortly be wound up and struck off.



Directors

The director shown below has held office during the period of
1 April 2021 to 28 February 2022

C Shanks


The director shown below has held office during the period of
1 April 2021 to 31 January 2022

S C Marnell


The director shown below has held office during the period of
31 January 2022 to 31 March 2022

M J Green


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
12 December 2022

And signed on behalf of the board by:
Name: M J Green
Status: Director

SHC PHARMACY LIMITED

Profit And Loss Account

for the Period Ended 31 March 2022

2022 2021


£

£
Turnover: 1,821,700 1,844,103
Cost of sales: ( 1,223,491 ) ( 1,178,452 )
Gross profit(or loss): 598,209 665,651
Administrative expenses: ( 461,945 ) ( 395,098 )
Other operating income: 11,314 34,280
Operating profit(or loss): 147,578 304,833
Interest payable and similar charges: ( 769 ) ( 752 )
Profit(or loss) before tax: 146,809 304,081
Profit(or loss) for the financial year: 146,809 304,081

SHC PHARMACY LIMITED

Balance sheet

As at 31 March 2022

Notes 2022 2021


£

£
Fixed assets
Tangible assets: 3 0 820
Total fixed assets: 0 820
Creditors: amounts falling due within one year: 6 ( 536,067 )
Net current assets (liabilities):   9,172
Total assets less current liabilities: 0 9,992
Provision for liabilities: ( 68 )
Total net assets (liabilities): 0 9,924
Capital and reserves
Called up share capital: 60 60
Profit and loss account: (60 ) 9,864
Total Shareholders' funds: 0 9,924

The notes form part of these financial statements

SHC PHARMACY LIMITED

Balance sheet statements

For the year ending 31 March 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 12 December 2022
and signed on behalf of the board by:

Name: M J Green
Status: Director

The notes form part of these financial statements

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is recognised at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to the customer net of discounts, VAT, and other sales-related taxes.Turnover from sale of goods is recognised when the risk and rewards of ownership of the goods have transferred to the buyer.

    Tangible fixed assets depreciation policy

    Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.Plant and machinery - 25% on costFixtures and fittings - 10% on costComputer Equipment - 25% on cost

    Other accounting policies

    Going concern: From 1 April 2022, the company ceased trading and will shortly be wound up and struck off. Thus, the financial statements are prepared on a basis other than going concern.Stocks: Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.Financial instruments: Basic financial instruments are recognised at amortised cost.Taxation: Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.Current or deferred taxation assets and liabilities are not discounted.Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the the period end and that are expected to apply to the reversal of the timing difference.Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is profitable and they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.Hire purchase leasing commitments: Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.Pension costs and other post-retirement benefits: The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

  • 2. Employees

    2022 2021
    Average number of employees during the period 13 11

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 April 2021 14,390 3,799 3,220 21,409
Additions
Disposals ( 14,390 ) ( 3,799 ) ( 3,220 ) ( 21,409 )
Revaluations
Transfers
At 31 March 2022 0 0 0 0
Depreciation
At 1 April 2021 14,390 3,480 2,719 20,589
Charge for year 95 322 417
On disposals ( 14,390 ) ( 3,575 ) ( 3,041 ) ( 21,006 )
Other adjustments
At 31 March 2022 0 0 0 0
Net book value
At 31 March 2022 0 0 0 0
At 31 March 2021 0 319 501 820

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

4. Stocks

2022 2021
£ £
Stocks 89,737
Total   89,737

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

5. Debtors

2022 2021
£ £
Trade debtors 166,394
Prepayments and accrued income 3,234
Other debtors 84,907
Total   254,535

SHC PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2022

6. Creditors: amounts falling due within one year note

  2021
  £
Trade creditors 246,782
Taxation and social security 63,922
Accruals and deferred income 178,008
Other creditors 47,355
Total   536,067